Sung, H. et al. International most cancers statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 nations. CA Most cancers J. Clin. 71, 209–249 (2021).
Begg, A. C., Stewart, F. A. & Vens, C. Methods to enhance radiotherapy with focused medication. Nat. Rev. Most cancers 11, 239–253 (2011).
Pitroda, S. P., Chmura, S. J. & Weichselbaum, R. R. Integration of radiotherapy and immunotherapy for therapy of oligometastases. Lancet Oncol. 20, e434–e442 (2019).
Nishiga, Y. et al. Radiotherapy together with CD47 blockade elicits a macrophage-mediated abscopal impact. Nat. Most cancers 3, 1351–1366 (2022).
Petroni, G., Cantley, L. C., Santambrogio, L., Formenti, S. C. & Galluzzi, L. Radiotherapy as a instrument to elicit clinically actionable signalling pathways in most cancers. Nat. Rev. Clin. Oncol. 19, 114–131 (2022).
Andratschke, N. et al. European Society for Radiotherapy and Oncology and European Organisation for Analysis and Remedy of Most cancers consensus on re-irradiation: definition, reporting, and scientific choice making. Lancet Oncol. 23, e469–e478 (2022).
Fattahi, S. et al. Reirradiation for locoregional recurrent breast most cancers. Adv. Radiat. Oncol. 6, 100640 (2021).
De Ruysscher, D., Faivre-Finn, C., Le Pechoux, C., Peeters, S. & Belderbos, J. Excessive-dose re-irradiation following radical radiotherapy for non-small-cell lung most cancers. Lancet Oncol. 15, e620–e624 (2014).
Beddok, A. et al. Scientific and technical challenges of most cancers reirradiation: phrases of knowledge. Crit. Rev. Oncol. Hematol. 174, 103655 (2022).
Liu, Y.-P. et al. Endoscopic surgical procedure in contrast with intensity-modulated radiotherapy in resectable regionally recurrent nasopharyngeal carcinoma: a multicentre, open-label, randomised, managed, part 3 trial. Lancet Oncol. 22, 381–390 (2021).
Xiang, G. et al. Re-irradiation for native primary-recurrence esophageal squamous cell carcinoma handled with IMRT/VMAT. Radiat. Oncol. 18, 114 (2023).
Mahantshetty, U. et al. Reirradiation with superior brachytherapy methods in recurrent GYN cancers. Brachytherapy 22, 753–760 (2023).
Huang, R.-X. & Zhou, P.-Ok. DNA injury response signaling pathways and targets for radiotherapy sensitization in most cancers. Sign Transduct. Goal. Ther. 5, 60 (2020).
Wang, Ok. & Tepper, J. E. Radiation therapy-associated toxicity: etiology, administration, and prevention. CA Most cancers J. Clin. 71, 437–454 (2021).
Yang, Y. et al. ZBP1-MLKL necroptotic signaling potentiates radiation-induced antitumor immunity by way of intratumoral STING pathway activation. Sci. Adv. 7, eabf6290 (2021).
Tam, S. Y., Wu, V. W. C. & Regulation, H. Ok. W. Affect of autophagy on the efficacy of radiotherapy. Radiat. Oncol. 12, 57 (2017).
Lei, G. et al. The function of ferroptosis in ionizing radiation-induced cell demise and tumor suppression. Cell Res. 30, 146–162 (2020).
Han, C. et al. The AIM2 and NLRP3 inflammasomes set off IL-1–mediated antitumor results throughout radiation. Sci. Immunol. 6, eabc6998 (2021).
Chen, H. et al. Radiotherapy modulates tumor cell destiny choices: a evaluate. Radiat. Oncol. 17, 196 (2022).
Tsvetkov, P. et al. Copper induces cell demise by focusing on lipoylated TCA cycle proteins. Science 375, 1254–1261 (2022).
Chen, L., Min, J. & Wang, F. Copper homeostasis and cuproptosis in well being and illness. Sign Transduct. Goal. Ther. 7, 378 (2022).
Cobine, P. A. & Brady, D. C. Cuproptosis: mobile and molecular mechanisms underlying copper-induced cell demise. Mol. Cell 82, 1786–1787 (2022).
Jin, X.-Ok. et al. Orchestrated copper-based nanoreactor for reworking tumor microenvironment to amplify cuproptosis-mediated anti-tumor immunity in colorectal most cancers. Mater. At present 68, 108–124 (2023).
Hasegawa, Ok., Saga, R. & Hosokawa, Y. Radiotherapeutic evaluate: acquisition of radioresistance and most cancers stem cell properties by way of irradiation. Radiat. Environ. Med. 12, 25–36 (2023).
Grey, M. et al. Growth and characterisation of acquired radioresistant breast most cancers cell traces. Radiat. Oncol. 14, 64 (2019).
Zhang, P., et al. Most cancers nanomedicine towards scientific translation: obstacles, alternatives, and future prospects. Med 4, 147–167 (2022).
Liu, L., Zhao, C., Miller, J. T. & Li, Y. Mechanistic research of CO2 photoreduction with H2O on Cu/TiO2 nanocomposites by in situ X-ray absorption and infrared spectroscopies. J. Phys. Chem. C 121, 490–499 (2017).
Wang, D. et al. In situ shaped Z-scheme graphdiyne heterojunction realizes NIR-photocatalytic oxygen evolution and selective radiosensitization for hypoxic tumors. ACS Nano 16, 21186–21198 (2022).
Ding, Z. et al. Radiotherapy reduces N-oxides for prodrug activation in tumors. J. Am. Chem. Soc. 144, 9458–9464 (2022).
Guo, Z. et al. Radiotherapy-induced cleavage of quaternary ammonium teams prompts prodrugs in tumors. Angew. Chem. Int. Ed. 61, e202205014 (2022).
Zhang, C. et al. Tumor microenvironment-responsive Cu2(OH)PO4 nanocrystals for selective and controllable radiosentization by way of the X-ray-triggered Fenton-like response. Nano Lett. 19, 1749–1757 (2019).
Wang, L., Jiang, N., Xu, H., Luo, Y. & Zhang, T. Hint Cu(II)-mediated selective oxidation of benzothiazole: the predominance of sequential Cu(II)–Cu(I)–Cu(III) valence transition and dissolved oxygen. Environ. Sci. Technol. 57, 12523–12533 (2023).
Zeng, L., Miller, E. W., Pralle, A., Isacoff, E. Y. & Chang, C. J. A selective turn-on fluorescent sensor for imaging copper in residing cells. J. Am. Chem. Soc. 128, 10–11 (2006).
Liu, X. et al. Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis. Nat. Cell Biol. 25, 404–414 (2023).
Xu, W. et al. Tumor microenvironment responsive hole nanoplatform for triple amplification of oxidative stress to reinforce cuproptosis-based synergistic most cancers remedy. Adv. Healthc. Mater. 12, 2202949 (2023).
Zhou, J. et al. Photothermally triggered copper payload launch for cuproptosis‐promoted most cancers synergistic remedy. Angew. Chem. Int. Ed. 62, e202213922 (2023).
Guo, B. et al. Cuproptosis induced by ROS responsive nanoparticles with elesclomol and copper mixed with αPD-L1 for enhanced most cancers immunotherapy. Adv. Mater. 35, 2212267 (2023).
Tang, D., Chen, X. & Kroemer, G. Cuproptosis: a copper-triggered modality of mitochondrial cell demise. Cell Res. 32, 417–418 (2022).
Zhao, B. et al. Photocatalysis-mediated drug-free sustainable most cancers remedy utilizing nanocatalyst. Nat. Commun. 12, 1345 (2021).
Ning, S. et al. Sort-I AIE photosensitizer loaded biomimetic system boosting cuproptosis to inhibit breast most cancers metastasis and rechallenge. ACS Nano 17, 10206–10217 (2023).
Chan, L. et al. Cuproptosis‐pushed enhancement of thermotherapy by sequentially response Cu2‐xSe by way of copper chemical transition. Adv. Funct. Mater. 33, 2302054 (2023).
Xu, W. et al. A hole amorphous bimetal natural framework for synergistic cuproptosis/ferroptosis/apoptosis anticancer remedy by way of disrupting intracellular redox homeostasis and copper/iron metabolisms. Adv. Funct. Mater. 32, 2205013 (2022).
Demaria, O. et al. Harnessing innate immunity in most cancers remedy. Nature 574, 45–56 (2019).
Kroemer, G., Galassi, C., Zitvogel, L. & Galluzzi, L. Immunogenic cell stress and demise. Nat. Immunol. 23, 487–500 (2022).
Fucikova, J. et al. Detection of immunogenic cell demise and its relevance for most cancers remedy. Cell Demise Dis. 11, 1013 (2020).
Liao, Y. et al. Piezoelectric supplies for synergistic piezo- and radio-catalytic tumor remedy. Nano At present 44, 101510 (2022).
Ni, Ok. et al. Synergistic checkpoint-blockade and radiotherapy–radiodynamic remedy by way of an immunomodulatory nanoscale steel–natural framework. Nat. Biomed. Eng. 6, 144–156 (2022).
Huang, Z. et al. Nanoscale coordination polymers induce immunogenic cell demise by amplifying radiation remedy mediated oxidative stress. Nat. Commun. 12, 145 (2021).
Min, Y. et al. Antigen-capturing nanoparticles enhance the abscopal impact and most cancers immunotherapy. Nat. Nanotechnol. 12, 877–882 (2017).
Melo, L. M. N., Lesner, N. P., Sabatier, M., Ubellacker, J. M. & Tasdogan, A. Rising metabolomic instruments to review most cancers metastasis. Developments Most cancers 8, 988–1001 (2022).
Li, H. et al. Nanomedicine embraces most cancers radio-immunotherapy: mechanism, design, current advances, and scientific translation. Chem. Soc. Rev. 52, 47–96 (2023).
Twyman-Saint Victor, C. et al. Radiation and twin checkpoint blockade activate non-redundant immune mechanisms in most cancers. Nature 520, 373–377 (2015).
Franken, N. A. P., Rodermond, H. M., Stap, J., Haveman, J. & Van Bree, C. Clonogenic assay of cells in vitro. Nat. Protoc. 1, 2315–2319 (2006).